This federal contract award, valued at $2,922.02, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of levothyroxin 100mcg tablets, a medication used to treat hypothyroidism, with a performance period through February 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $8,598.41, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 1,000 units of the drug Levothyroxine 125 mcg tablets, a medication used to treat thyroid disorders. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,389.64 firm fixed-price delivery order is for the supply of 4,565,645,156 units of the prescription medication levothyroxine 112 mcg tablets. The contract has a ceiling value of $2,389.64 and an ultimate completion date of September 3, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,225.95 Firm Fixed Price Delivery Order contract is for the supply of 4565057401 - Levothyroxine 50 MCG Tablet, 1000's. The contract has a period of performance through July 3, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support...
This federal contract award, valued at $2,892.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of levothyroxine 100 mcg vials, a medication used to treat hypothyroidism. The contract has a firm fixed price pricing type and an ultimate completion date of May 7, 2025. This award is not associated with a set-aside program, indicating open competition....
This federal contract award is a delivery order with a firm fixed price valued at $1,167.18, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the supply of 4,565,749,812 units of Levothyroxine 50 MCG Tablets, a medication used to treat hypothyroidism. The ultimate completion date for this delivery order is September 11, 2024. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Levothyroxine 137 MCG Tablets in 1,000-count quantities, with a ceiling value of $1,617.60 and a performance period through October 31, 2023. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,323.52, is for the delivery of 1,000 units of the medication Levothyroxine 112 MCG Tablet. The contract has a firm fixed price and is scheduled for completion by September 15, 2023. The award was made on September 14, 2023, and there was no set-aside...
The Defense Logistics Agency (DLA) awarded a $1,092.69 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of 4,563,189,790 units of 112 mcg Levothyroxine tablets. This contract, with an ultimate completion date of December 28, 2023, is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that specializes in supplying a wide range of medical products, including specialty medications,...
This federal contract award, with ID SPE2DB25D3003|SPE2DB25FPVTQ, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Levothyroxine 112 MCG Capsules in 30-count packages, with a ceiling value of $1,042.29 and a performance period ending on February 11, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that...